Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation rate of the CDKN2 gene in malignant gliomas.

Cancer research - 15 Dec 1994

Giani C, Finocchiaro G

Abstract excerpt

The CDKN2 gene encodes p16, a protein controlling the cell cycle. CDKN2 is deleted in a relevant number of tumor cell lines, but results of the studies in primary tumors are contradictory. We have investigated by using quantitative polymerase chain reaction and single-strand conformation polymorphism analysis the structure of exon 2 of CDKN2 in 32 malignant gliomas. In 11 tumors the amount of amplified material...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Carrier Proteins
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glioma

Share to Molecular Sequence Data

Share to Mutation

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 7987825

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation rate of the CDKN2 gene in malignant gliomas.PMID 7987825Read ↗

Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursSemantic proximity Read ↗

Loss of P16INK4 expression is frequent in high grade gliomas.Semantic proximity Read ↗

Mutations of the p16 gene in gliomas.Semantic proximity Read ↗

Frequent mutations of CDKN2 in primary pancreatic adenocarcinomas.Semantic proximity Read ↗

Hemizygous or homozygous deletion of the chromosomal region containing the p16INK4a gene is associated with amplification of the EGF receptor gene in glioblastomas.Semantic proximity Read ↗

Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck.Semantic proximity Read ↗

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.Semantic proximity Read ↗

Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens.Semantic proximity Read ↗

Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancerSemantic proximity Read ↗

No CDKN2 mutations in neuroblastomas.Semantic proximity Read ↗

CDKN2 mutation is infrequent in german hepatocellular carcinoma.Semantic proximity Read ↗

Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, andCDKN2C) in childhood rhabdomyosarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.